Content about Valeant Pharmaceuticals International

August 18, 2011
Board member at Valeant steps down

Valeant Pharmaceuticals on Thursday announced the resignation of Michael Van Every from its board of directors.

July 20, 2011
Valeant inks distribution agreement for Zuacta in Canada

Canadian drug maker Valeant Pharmaceuticals International has signed an agreement with Sanofi’s subsidiary in Canada to distribute a topical medication for osteoarthritis in the country.

July 15, 2011
Valeant Pharmaceuticals purchases Johnson & Johnson dermatology subsidiary

Valeant Pharmaceuticals has purchased a dermatology subsidiary from Johnson & Johnson, the Canadian drug maker said Friday.

July 14, 2011
Sanofi sells skin care business to Valeant Pharmaceuticals International

French drug maker Sanofi has sold its skin care business to Canada’s Valeant Pharmaceuticals International, Sanofi said.

June 30, 2011
Valeant buys rights for Elidel, Xerese

Canadian drug maker Valeant Pharmaceuticals International will acquire rights to topical drugs for eczema and cold sores from Swedish drug maker Meda.

June 13, 2011
GSK, Valeant receive FDA approval for Potiga

The Food and Drug Administration has approved a new drug for epilepsy made by GlaxoSmithKline and Valeant Pharmaceuticals International, the drug makers said Monday.

May 18, 2011
Valeant's Kinerase brand to make charitable donations as part of campaign

Valeant Pharmaceuticals has announced the launch of the "Change Your Skin, Change Your Life" campaign, in which its Kinerase brand will make three charitable donations in 2011.

May 2, 2011
Teva comes up as front-runner to buy Cephalon

Cephalon has another suitor in the form of the world’s largest generic drug company.

April 22, 2011
Valeant issues letter to Cephalon stockholders

Valeant Pharmaceuticals International is taking its case directly to Cephalon’s shareholders in its effort to acquire the Frazer, Pa.-based drug maker.

April 21, 2011
GSK, Valeant respond to CRL for ezogabine

GlaxoSmithKline and Valeant last week responded to the Food and Drug Administration's complete response letter for the companies' investigational anti-epileptic drug.

March 30, 2011
Valeant seeks to buy Cephalon

Canadian drug maker Valeant Pharmaceuticals has proposed to buy Cephalon for $5.7 billion, Valeant said Tuesday.

March 22, 2011
Valeant CEO named chairman of the board

J. Michael Pearson has been appointed to chairman of the board at Valeant Pharmaceuticals, the drug maker said Tuesday.

February 18, 2011
ReportersNotebook — Chain Pharmacy, 2/28/11

SUPPLIER NEWS — Drug maker Valeant Pharmaceuticals International has acquired U.S. and Canadian rights to certain formulations of a GlaxoSmithKline drug used to treat cold sores. Valeant acquired the rights to nonophthalmic topical formulations of Zovirax (acyclovir) from GSK for $300 million through its Canadian subsidiary, Biovail Labs.



February 8, 2011
Biovail Labs to distribute Aczone in Canada

Valeant Pharmaceuticals subsidiary Biovail Labs International has licensed Canadian rights to a treatment for acne from Allergan, Valeant said Tuesday.

February 3, 2011
Valeant receives U.S., Canadian rights for Zovirax

Drug maker Valeant Pharmaceuticals International has acquired U.S. and Canadian rights to certain formulations of a GlaxoSmithKline drug used to treat cold sores.

December 20, 2010
Valeant names interim CFO

Valeant Pharmaceuticals' former SVP and corporate controller has been appointed to the role of interim CFO.

October 31, 2010
Biovail Labs International to acquire privately owned skin care brands

Valeant Pharmaceuticals International's subsidiary Biovail Labs International has agreed to acquire several privately owned skin...

October 31, 2010
Valeant, Kadmon to partner on antiviral drug development

Drug makers Valeant Pharmaceuticals International and Kadmon Pharmaceuticals will collaborate to develop antiviral drugs for...

October 19, 2010
Kinerase announces new skin care line for mass

Clinical skin care brand Kinerase, which has a long history of creating high-end skin care...

September 27, 2010
Valeant, Biovail become one

The merger between Valeant Pharmaceuticals International and Biovail is complete, the two companies said Tuesday....

August 30, 2010
FDA pushes back GSK-Valeant drug review

The Food and Drug Administration has pushed back its review date for a drug made...

August 11, 2010
FDA advisory committee recommends approval for ezogabine

A Food and Drug Administration advisory committee has given a nod of approval to an...

June 22, 2010
Valeant announces market availability of Oxsoralen-Ultra

Valeant Pharmaceuticals has made a treatment for psoriasis available again, following a shortage, the drug...

June 20, 2010
Valeant, Biovail to merge

U.S. drug maker Valeant and Canadian drug maker Biovail will merge, the two companies said...

March 18, 2010
Valeant buys OTC, generic drug maker

A U.S. drug maker has bought a manufacturer of branded generics and OTC products in...

© 2013 Drug Store News. All Rights Reserved.